Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Exploring mechanisms of sex differences in longevity: lifetime ovary exposure and exceptional longevity in dogs.

Waters DJ, Kengeri SS, Clever B, Booth JA, Maras AH, Schlittler DL, Hayek MG.

Aging Cell. 2009 Dec;8(6):752-5. doi: 10.1111/j.1474-9726.2009.00513.x. Epub 2009 Sep 2.

2.

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.

Boria PA, Murry DJ, Bennett PF, Glickman NW, Snyder PW, Merkel BL, Schlittler DL, Mutsaers AJ, Thomas RM, Knapp DW.

J Am Vet Med Assoc. 2004 Feb 1;224(3):388-94.

PMID:
14765798
3.

Exceptional longevity in pet dogs is accompanied by cancer resistance and delayed onset of major diseases.

Cooley DM, Schlittler DL, Glickman LT, Hayek M, Waters DJ.

J Gerontol A Biol Sci Med Sci. 2003 Dec;58(12):B1078-84.

PMID:
14684704
4.

Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Schlittler DL, Coffman KT, Bonney PL, Knapp DW.

Mol Cancer Ther. 2003 Feb;2(2):183-8.

5.

Endogenous gonadal hormone exposure and bone sarcoma risk.

Cooley DM, Beranek BC, Schlittler DL, Glickman NW, Glickman LT, Waters DJ.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1434-40.

Supplemental Content

Loading ...
Support Center